BCL11A enhancer–edited hematopoietic stem cells persist in rhesus monkeys without toxicity
Selami Demirci(National Institutes of Health), John F. Tisdale(National Heart Lung and Blood Institute), Anne H. Shen(Broad Institute), Jackson Gamer(National Institute of Diabetes and Digestive and Kidney Diseases), Scot A. Wolfe(University of Massachusetts Chan Medical School), Nathaniel S. Linde(National Institutes of Health), Shondra M. Pruett‐Miller(St. Jude Children's Research Hospital), Aylin Bonifacino(National Institutes of Health), Alexis Leonard(St. Jude Children's Research Hospital), Naoya Uchida(National Heart Lung and Blood Institute), Yuxuan Wu(Qufu Normal University), Juan J. Haro‐Mora(National Institutes of Health), Claire Drysdale(National Institute of Diabetes and Digestive and Kidney Diseases), Theresa Engels(National Institutes of Health), Cícera R. Lazzarotto(St. Jude Children's Research Hospital), Jing Zeng(Broad Institute), Kevin Luk(University of Massachusetts Chan Medical School), Mitchell J. Weiss(St. Jude Children's Research Hospital), Tina Nassehi(National Institute of Diabetes and Digestive and Kidney Diseases), Morgan Yapundich(National Institute of Diabetes and Digestive and Kidney Diseases), Daniel E. Bauer(Broad Institute), Jasmine Bonanno(Dana-Farber Cancer Institute), Robert E. Donahue(National Institute of Diabetes and Digestive and Kidney Diseases), Danilo Pellin(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Allen E. Krouse(National Institutes of Health), Shengdar Q. Tsai(Harvard University), Shaina N. Porter(St. Jude Children's Research Hospital)
Cited by 67
Related Papers
Efficient genome editing in zebrafish using a CRISPR-Cas system
|Nature Biotechnology|2013|3k
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
|Nature|2016|2.7k
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
|Nature Biotechnology|2014|2.3k
CRISPResso2 provides accurate and rapid genome editing sequence analysis
|Nature Biotechnology|2019|1.8k
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
|Nature|2015|1.7k